Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria
- PMID: 1952852
- PMCID: PMC245275
- DOI: 10.1128/AAC.35.9.1824
Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria
Abstract
Antimicrobial agents are most often tested against bacteria in the log phase of multiplication to produce the maximum bactericidal effect. In an infection, bacteria may multiply less optimally. We examined the effects of several classes of antimicrobial agents to determine their actions on gram-positive and gram-negative bacteria during nongrowing and slowly growing phases. Only ciprofloxacin and ofloxacin exhibited bactericidal activity against nongrowing gram-negative bacteria, and no antibiotics were bactericidal (3-order-of-magnitude killing) against Staphylococcus aureus. For the very slowly growing gram-negative bacteria studied, gentamicin (an aminoglycoside), imipenem (a carbapenem), meropenem (a carbapenem), ciprofloxacin (a fluoroquinolone), and ofloxacin (a fluoroquinolone) exhibited up to 5.7 orders of magnitude more killing than piperacillin or cefotaxime. This is in contrast to optimally growing bacteria, in which a wide variety of antibiotic classes produced 99.9% killing. For the gram-positive and gram-negative bacteria we examined, antibiotic killing was greatly dependent on the growth rate. The clinical implications of slow killing by chemotherapeutic agents for established bacterial infections and infections involving foreign bodies are unknown.
Similar articles
-
Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria.Eur J Clin Microbiol Infect Dis. 1993 May;12(5):372-7. doi: 10.1007/BF01964437. Eur J Clin Microbiol Infect Dis. 1993. PMID: 8394816
-
Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.Int J Antimicrob Agents. 2005 Dec;26(6):463-72. doi: 10.1016/j.ijantimicag.2005.08.016. Epub 2005 Nov 8. Int J Antimicrob Agents. 2005. PMID: 16280243 Free PMC article.
-
Antibacterial properties of BO-2727, a new carbapenem antibiotic.J Antimicrob Chemother. 1997 Aug;40(2):195-203. doi: 10.1093/jac/40.2.195. J Antimicrob Chemother. 1997. PMID: 9301984
-
A review of the antimicrobial activity of the fluoroquinolones.J Chemother. 1990 Oct;2(5):280-94. doi: 10.1080/1120009x.1990.11739031. J Chemother. 1990. PMID: 2128638 Review.
-
Parenteral carbapenems.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:175-80. doi: 10.1111/j.1469-0691.2007.01868.x. Clin Microbiol Infect. 2008. PMID: 18154543 Review.
Cited by
-
Distinct Bacterial Pathways Influence the Efficacy of Antibiotics against Mycobacterium tuberculosis.mSystems. 2020 Aug 4;5(4):e00396-20. doi: 10.1128/mSystems.00396-20. mSystems. 2020. PMID: 32753506 Free PMC article.
-
The physiology and genetics of bacterial responses to antibiotic combinations.Nat Rev Microbiol. 2022 Aug;20(8):478-490. doi: 10.1038/s41579-022-00700-5. Epub 2022 Mar 3. Nat Rev Microbiol. 2022. PMID: 35241807 Review.
-
Crude metabolites from endophytic fungi inhabiting Cameroonian Annona muricata inhibit the causative agents of urinary tract infections.PLoS One. 2022 May 11;17(5):e0267246. doi: 10.1371/journal.pone.0267246. eCollection 2022. PLoS One. 2022. PMID: 35544583 Free PMC article.
-
Potentiation of Aminoglycoside Lethality by C4-Dicarboxylates Requires RpoN in Antibiotic-Tolerant Pseudomonas aeruginosa.Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01313-19. doi: 10.1128/AAC.01313-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31383655 Free PMC article.
-
Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic.Nat Commun. 2019 Mar 12;10(1):1177. doi: 10.1038/s41467-019-09058-4. Nat Commun. 2019. PMID: 30862812 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical